• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    552374.pdf
    Size:
    878.7Kb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Jiyad, Z
    Olsen, C
    Burke, M
    Isbel, N
    Green, Adèle C
    Affiliation
    Cancer and Population Studies Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland
    Issue Date
    2016-05-10
    
    Metadata
    Show full item record
    Abstract
    Azathioprine, a purine antimetabolite immunosuppressant, photosensitises the skin and causes the production of mutagenic reactive oxygen species. It is postulated to increase the risk of squamous cell carcinoma (SCC) and other skin cancers in organ transplant recipients (OTRs), but evidence from multiple, largely single-centre studies to date has been inconsistent. We aimed to resolve the issue of azathioprine's carcinogenicity by conducting a systematic review of the relevant literature and pooling published risk estimates to evaluate the risks of SCC, basal cell carcinoma (BCC), keratinocyte cancers (KC) overall, and other skin cancers, in relation to azathioprine treatment. 27 studies were included in total, with risk estimates from 13 of these studies able to be pooled for quantitative analysis. The overall summary estimate showed a significantly increased risk of SCC in relation to azathioprine exposure (1.56, 95% confidence interval, CI, 1.11-2.18). No significant associations between azathioprine treatment and BCC (0.96, 95% CI 0.66-1.40) or KC (0.84, 95% CI 0.59-1.21) risk were observed. There was significant heterogeneity between studies for azathioprine risk estimates and the outcomes of SCC, BCC and KC. The pooled findings of available evidence support the contention that treatment with azathioprine increases the risk of SCC in OTRs. This article is protected by copyright. All rights reserved.
    Citation
    Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis. 2016: Am J Transplant
    Journal
    American Journal of Transplantation
    URI
    http://hdl.handle.net/10541/614565
    DOI
    10.1111/ajt.13863
    PubMed ID
    27163483
    Type
    Article
    Language
    en
    ISSN
    1600-6143
    ae974a485f413a2113503eed53cd6c53
    10.1111/ajt.13863
    Scopus Count
    Collections
    All Paterson Institute for Cancer Research

    entitlement

    Related articles

    • Azathioprine and risk of non-melanoma skin cancers in organ transplant recipients: a systematic review and update meta-analysis.
    • Authors: Kreuz M, Cardoso JCO, Sobreira LER, Cavalcanti Souza ME, Campos LE, Kelly FA, de Moraes FCA
    • Issue date: 2025 Jul
    • Sun protection for preventing basal cell and squamous cell skin cancers.
    • Authors: Sánchez G, Nova J, Rodriguez-Hernandez AE, Medina RD, Solorzano-Restrepo C, Gonzalez J, Olmos M, Godfrey K, Arevalo-Rodriguez I
    • Issue date: 2016 Jul 25
    • Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.
    • Authors: Mellon L, Doyle F, Hickey A, Ward KD, de Freitas DG, McCormick PA, O'Connell O, Conlon P
    • Issue date: 2022 Sep 12
    • St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.
    • Authors: Miranda BH, Shahid S, Corriero A, Zhang J, Kosasih S, El-Muttardi N
    • Issue date: 2025 Jun 20
    • Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
    • Authors: Webster AC, Wu S, Tallapragada K, Park MY, Chapman JR, Carr SJ
    • Issue date: 2017 Jul 20
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.